Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-35,424
Closed -$171K 4496
2025
Q3
$171K Sell
35,424
-24,470
-41% -$134K ﹤0.01% 3990
2025
Q2
$332K Buy
+59,894
New +$474K ﹤0.01% 3606
2022
Q3
Sell
-996
Closed -$9K 3160
2022
Q2
$9K Buy
+996
New +$11.6K ﹤0.01% 2794
2022
Q1
Sell
-16,362
Closed -$930K 3113
2021
Q4
$930K Buy
16,362
+6,487
+66% +$433K ﹤0.01% 1745
2021
Q3
$745K Buy
9,875
+2,793
+39% +$296K ﹤0.01% 1741
2021
Q2
$1.19M Buy
7,082
+6,246
+747% +$1.09M ﹤0.01% 1514
2021
Q1
$147K Sell
836
-9,164
-92% -$1.85M ﹤0.01% 2796
2020
Q4
$2.05M Sell
10,000
-9,560
-49% -$1.78M 0.02% 931
2020
Q3
$3.82M Buy
+19,560
New +$4.71M 0.05% 420

Other funds holding GOCO

Squarepoint's GOCO Position: Q4 2025 in Review

Squarepoint sold out of GoHealth (GOCO) in Q4 2025, closing a stake of 35,424 shares — an estimated $171K sold.

Squarepoint first reported a position in GOCO in Q3 2020 and held it in 9 quarters. The position peaked at $3.82M in Q3 2020. 56 funds tracked by Wall St. Rank hold GOCO as of Q4 2025.

  • Squarepoint reported no remaining GoHealth position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 35,424 GoHealth shares in Q4 2025, an estimated $171K.
  • Squarepoint first reported a position in GoHealth in Q3 2020 and held it in 9 quarters.
  • Squarepoint's GoHealth position peaked at $3.82M in Q3 2020.
  • 56 funds tracked by Wall St. Rank held GoHealth as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.